Neutral ph hair removal method with new reducing agents
A novel hair removal method using neutral pH reducing agents to minimize skin damage and unpleasant odors. Developed by the University of Melbourne, this solution offers a safer and more pleasant alternative to traditional hair removal techniques.
Overview
Traditional hair removal methods often involve high alkaline pH and thiol-containing reducing agents, which can cause skin damage and emit unpleasant odors. Our research, conducted at the University of Melbourne, focuses on developing a safer, more effective hair removal technique. This method employs novel reducing agents that operate at a neutral pH, reducing the risk of skin irritation and improving user comfort. Additionally, a complementary skin cream has been developed to moisturize and vitalize the skin post-depilation.
Technical specifications
- Neutral pH reducing agents: These agents minimize skin damage and reduce unpleasant odors, unlike traditional thiol-based solutions.
- High protein yield: The new method allows for effective extraction of keratin proteins without damaging the fibers.
- Complementary skin cream: A specially formulated cream enhances skin vitality and moisture after hair removal.
Technology readiness level
The technology is currently at TRL 4, indicating that it has been validated at the lab scale. Future validations will involve testing on animal skin and human volunteers to optimize conditions and ensure safety and efficacy.
About The University of Melbourne
The University of Melbourne is a comprehensive institution spanning STEM, health and clinical practice, business and law, and the creative and social disciplines. Co‑located hospital and research precincts, together with an inner‑city innovation ecosystem, place companies, startups, and researchers in shared labs, prototyping spaces, and studios. Engineering and technology programs connect with advanced manufacturing facilities, while structured industry projects and placements link partners with talent and translational problem‑solving. Work is supported by competitive funding from the Australian Research Council and the National Health and Medical Research Council, with additional backing from state programs and industry partners; a dedicated technology transfer office manages IP, licensing, and startup formation.
delivered to your inbox.